LyncBio Therapeutics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch LyncBio Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants (NCT07505030) | LyncBio Therapeutics Co., Ltd. | 2026-05-25 |
Track LyncBio Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.